Arsia Therapeutics (Biotechnology, Health and Wellness) — Funding, Investors & Signals 2026

Arsia Therapeutics

Enhancing accessibility and patient comfort while lowering healthcare costs through advanced subcutaneous delivery of life-saving drugs.

Founded 2013 Seed Biotechnology, Health and Wellness

Arsia Therapeutics is a biotechnology startup founded in 2013 with a mission to enhance accessibility to life-saving drugs and reduce healthcare expenses through advanced subcutaneous delivery. The company focuses on addressing the challenges related to the administration of biologics, which are inherently larger and more delicate than conventional medications, often requiring larger doses and injection-based delivery. The Seed Round investment at 01 January 2015 from Polaris Partners has provided crucial support to Arsia's innovative approach. By leveraging a proprietary platform technology, Arsia aims to create high-concentration biopharmaceutical products with low viscosity suitable for subcutaneous injection. This not only improves patient comfort by offering at-home administration but also has the potential to significantly lower healthcare costs by reducing the need for hospital visits. Arsia's unique formulation solution not only addresses viscosity challenges for new products but also provides a life-cycle management strategy for existing products in the market. The company's dedication to enhancing drug delivery is not only innovative but also showcases potential for differentiation in the competitive pharmaceutical landscape. In conclusion, Arsia Therapeutics holds promising potential in the biotechnology industry, driven by its dedication to advancing drug delivery methods, improving patient comfort, and reducing healthcare costs. With the support of Polaris Partners, the company is well-positioned to make a significant impact in the accessibility and delivery of life-saving drugs.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	••••••	1		01 Jan 2015

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

••••••

01 Jan 2015

FAQ About Arsia Therapeutics

Enhancing accessibility and patient comfort while lowering healthcare costs through advanced subcutaneous delivery of life-saving drugs.

Arsia Therapeutics was founded in 2013.

Arsia Therapeutics operates in the following industries: Biotechnology, Health and Wellness.

Arsia Therapeutics has completed 1 funding round. The latest funding stage is Seed.

Top alternatives and competitors to Arsia Therapeutics include Comera Life Sciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Arsia Therapeutics and Comera Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Arsia Therapeutics

General Information

Track Arsia Therapeutics

Discover More

About Arsia Therapeutics

Funding Rounds & Investors (1)

Arsia Therapeutics Alternatives & Competitors

FAQ About Arsia Therapeutics

Don't just browse. Track.